Skip Navigation

Publicaciones covid-9

Resource Feedback

If you know about a problem with one of our resource records, we want to know about it!

Resource Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
URL https://www.sciencedirect.com/science/article/pii/S0140673621016949?via%3Dihub
(if you would like a response)
Verification Code:
CAPTCHA Image
Reload Image